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Dear Sir,
We read with great interest the article entitled “Simultaneous
determination of Δ9-tetrahydrocannabinol and 11-nor-9-car-
boxy-Δ9-tetrahydrocannabinol in oral fluid using isotope dilu-
tion liquid chromatography tandem mass spectrometry” by Lee
et al. [1]. The authors describe a fast and very sensitive method
to analyse dansyl derivatives ofΔ9-tetrahydrocannabinol (THC)
and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (THCCOOH)
in oral fluid with limits of quantification of 25 and 5 pg/mL,
respectively. Generally, liquid chromatography (LC)–mass
spectrometry (MS) is preferred over gas chromatography–MS
because it does not require prior derivatization and extensive
sample clean-up, making this approach much less tedious and
time consuming. However, this common rule has several excep-
tions. In this regard, there are some substances that do not show
a signal sufficiently intense with the classic ion sources com-
monly used in LC-MS. Typically, the phytocannabinoids be-
long to this family. To overcome this problem, derivatization
can be used to improveMS/MS detectability [2]. In this respect,
Lee et al. reported the use of a chemical derivatization approach
using isotope dilution LC-MS/MS with electrospray ionization
in positive mode to detect and quantify THC and THCCOOH.
Derivatization of the phenolic group was done with dansyl
chloride (DC) at basic pH (10.5) at 70 °C for 5 min.
This method was tested in our laboratory with oral fluid
samples spiked with a broader range of cannabinoids: THC,
THCCOOH, 11-hydroxy-THC (11-OH-THC), cannabinol,
cannabidiol, the two glucuronide conjugates THC–glucuro-
nide (THC-gluc) and THCCOOH–glucuronide (THCCOOH-
gluc) and the plant precursor of THC, Δ9-tetrahydrocannabi-
nolic acid A (THC-A). All except 11-OH-THC are known to
be present in oral fluid, a few at high concentrations (THC,
THC-A, cannabidiol), others in only tiny amounts (mainly the
THC metabolites and their conjugates). Since this method
involving derivatization followed by LC-MS/MS analysis
has been advocated with other biological matrices, its evalu-
ation with a more expanded range of cannabinoids is even
more warranted.
Pure and dansylated standards were analysed first to deter-
mine the ion transitions and the best MS/MS parameters.
Then, drug-free oral fluid samples spiked at different concen-
trations (5, 25, 50, 100, 250, 500 and 1,000 pg/mL) with the
whole range of cannabinoids were pretreated, derivatized and
extracted according to the protocol developed by Lee et al. [1].
These samples were also extracted according to our own
procedure, which does not include a derivatization step [3].
Briefly, our method is as follows. To 250 μL of oral fluid, we
added 10μL of an internal standard solution of 5 ng/mLTHC-
d3, 11-OH-THC-d3 and THCCOOH-d9. Then, the volume
was made up to 1 mL with ammonium formate buffer
(10 mM, pH 6.5) and the mixture was vortexed for 5 s. Oasis
HLB extraction columns (Waters, Baden, Switzerland) were
conditioned with 2 mL of methanol, 2 mL of deionized water
and 2 mL of ammonium formate buffer (10 mM, pH 6.5). The
samples were loaded by gravity. Cannabinoids were eluted
with 3 mL of methanol. The eluates were evaporated to
dryness and reconstituted in 150 μL of ammonium formate
buffer (5 mM, pH 6.8)–acetonitrile (70:30, v/v). For both
procedures, the LC parameters and the MS/MS equipment
were the same. The separation was done on a Kinetex™ C18
100-Å column (150 mm×2.1 mm inner diameter, 2.6 μm),
(Phenomenex, Brechbühler, Echallens, Switzerland). Gradient
elution was performed using a mixture of ammonium formate
buffer at 5 mM, pH 6.8 (solvent A) and acetonitrile (solvent B)
M. Fabritius :C. Giroud (*)
Forensic Toxicology and Chemistry Unit,
University Center of Legal Medicine,
Rue du Bugnon 21,
1011 Lausanne, Switzerland
e-mail: christian.giroud@chuv.ch
Anal Bioanal Chem (2013) 405:435–437
DOI 10.1007/s00216-012-6515-4
at a flow rate of 400 μL/min. The initial gradient conditions
were as follows: 30% solvent B, hold for 30 s, and then linearly
increase to reach 90% solvent B at 7 min. The conditions using
90 % solvent B were maintained for 2 min. Then, the gradient
was decreased to 30% solvent B over 30 s and held for 2.5min.
Then, 10 μL of the sample was injected into the LC-MS/MS
system. Analytes were detected using an Applied Biosystems
SCIEX API 5000 triple-quadrupole mass spectrometer with a
TurboIonSpray interface. As described by Lee et al., the dansy-
lated derivates were registered in positive electrospray ioniza-
tion mode with the same multiple reaction monitoring
transitions. In our procedure, MS transitions were recorded
using a scheduled multiple reaction monitoring mode with
three separate time windows. The first time window (from the
start to 5.1 min) was operated in negative ionization mode,
whereas the second (from 5.1 to 6.4 min) and the third (from
6.4 to 7.5 min) windows were operated in the positive mode.
THC-A, THCCOOH and the glucuronides were analysed in
the negative mode to achieve better sensitivity.
Specific analyses for THC-A and glucuronide conjugates
were also conducted. Drug-free oral fluid samples were spiked
with THC-A, THC-gluc or THCCOOH-gluc at a concentra-
tion of 100 ng/mL and were analysed with the method of Lee
et al. As deuterated homologues of these compounds were not
commercially available, THC-d3 was used as the internal
standard for THC-gluc and THCCOOH-d9 was selected for
THC-A and THCCOOH-gluc. Calibration curves were
obtained with six calibration levels (0.1, 0.5, 5, 10, 25 and
50 ng/mL) for THC, THCCOOH, cannabidiol, cannabinol
and 11-OH-THC.
Therefore, two different methods in the analysis of canna-
binoids in oral fluid were used and compared. What differ-
entiates these two methods is the dansylation step used by Lee
et al. as it combines a simple liquid–liquid extraction, whereas
our method does not require any derivatization even though it
involves a longer purification on solid-phase cartridges. This
latter step was necessary to extract the underivatized glucuro-
nide conjugates from oral fluid. Derivatization with DC was
done at basic pH (10.5) and 70 °C for 5 min. With the method
developed in our laboratory, samples were analysed straight-
forwardly at almost neutral pH (6.8) and without heating. The
other parts of the methods were similar and rely upon LC-MS/
MS analysis with electrospray ionization and reverse-phase
chromatographic separation using a C18 column.
Our results confirm and extend those of Lee et al.: the
sensitivity for THC and THCCOOH detection was improved,
as was that for cannabinol, cannabidiol and 11-OH-THC
detection. In this respect, the limits of detection (LOD) were
lower for these five cannabinoids using the method developed
by Lee et al.: the LOD of THCCOOH, 11-OH-THC and
cannabinol decreased from 100 to 5 pg/mL, the LOD of
THC decreased from 50 to 25 pg/mL and the LOD of canna-
bidiol was 50 pg/mL with DC derivatization, whereas it was
300 pg/mL with our method. However, we failed to detect the
dansylated THC-A, THC-gluc and THCCOOH-gluc. The
reasons of their non-detection were investigated, and one of
the most important factors could be the derivatization condi-
tions. It has been proved that THC-A degrades into THC at
high temperature [4]. Incubation of DC with cannabinoids at
70 °C for several minutes could lead at least to partial thermal
conversion of THC-A into THC. Furthermore, the basic con-
ditions (obtained with 100 mM sodium bicarbonate buffer at
pH 10.5) have been proved to be sufficient to hydrolyse
THCCOOH-gluc [5] and could explain the non-detection of
the glucuronide conjugates.
To test these hypotheses, the following experiments were
performed to assess whether THC-A is converted into THC
and whether the glucuronides are hydrolysed to their
corresponding free cannabinoids during the dansylation step.
Drug-free oral fluid samples were spiked with THC-A, THC-
gluc or THCCOOH-gluc at a concentration of 100 ng/mL.
Samples were extracted and analysed according to the proto-
col developed by Lee et al. [1]. For the oral fluid specimens
spiked with THCCOOH-gluc, DC-THCCOOHwas measured
at a concentration of 20 ng/mL. Taking into account their
molar differences, we found that more than 30 % of
THCCOOH-gluc was hydrolysed to THCCOOH during the
derivatization process. For samples spiked with THC-A, DC-
THC was detected at a concentration of 9 ng/mL. This level
corresponds to 10 % of the initial concentration of THC-A.
For THC-gluc samples, only 2 ng/mL DC-THC was detected
(4 %). As expected, our analyses revealed that dansylation
resulted in significant hydrolysis of THCCOOH-gluc to
THCCOOH. For THC-A and THC-gluc, THC was detected
in low concentrations only. These results indicate that the
glucuronide conjugates of THC and THC-A are partly con-
verted into THC when dansylated. Therefore, quantitative
results of dansylated cannabinoids must be interpreted with
great caution because they represent a partial sum of free and
conjugated metabolites of THC and THC-A. However, if
qualitative results only are required, the method using dansy-
lation should be preferred because it has better sensitivity. For
blood, this method is not recommended because the concen-
trations of free cannabinoids could be wrongly increased.
More than 80 metabolites of THC have been identified [6].
In 2007, Jung et al. [7], who studied the metabolism of THC-A,
reported 12 THC-A metabolites. We suggest that THC-gluc,
THCCOOH-gluc, THC-A and other metabolites are also de-
graded, possibly into polymers, oxidized compounds and other
cannabinoids that could not be detected with our analytical
method. Recently, Schwilke et al. [8] suggested that the ether–
glucuronide bond in THC is stabler than the ester–glucuronide
bond in THCCOOH. This difference could explain the greater
hydrolysis of THCCOOH-gluc compared with THC-gluc.
In the experimental design of Lee et al. [1], oral fluid
samples of suspected cannabis users were analysed. They
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were not concerned with the fact that after a user has smoked a
joint, a significant amount of THC-A can be found in oral
fluid [3, 9]. In this respect, THC-Awas detected at a concen-
tration of 1 ng/mL byMoore et al. [9] until 8 h after a user had
smoked a joint. In another study, we detected THC-A until the
end of the experiment, this being 4 h after the first puff of the
joint had been inhaled. THCCOOH-gluc in very low concen-
trations was also detected.
As a conclusion, to obtain accurate measurements
and a better comparison of results between laboratories,
a method able to quantify separately each cannabinoid
should be preferred. Furthermore, our results show that
some minor cannabinoids and their metabolites which
could be used as biomarkers to substantiate use [10]
and/or to estimate the last time of use cannot be mea-
sured separately after derivatization with DC. Very re-
cently, another approach was suggested by Coulter et al.
[11], who advocate the use of picolylamine to derivatize
the carboxylic function of THCCOOH in order to
achieve the requisite sensitivity.
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